Keywords: elan, completes, ziconotide, phase, iii, neuropathic, pain

Elan Completes Ziconotide Phase III In Neuropathic Pain

Article | 15 December 1998

Print This

The results of Elan's completed Phase III trial of ziconotide (SNX-111)for the treatment of neuropathic pain in patients who ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in